Atossa Therapeutics, Inc. (ATOS)
NASDAQ: ATOS · Real-Time Price · USD
1.200
-0.080 (-6.25%)
At close: Nov 20, 2024, 4:00 PM
1.190
-0.010 (-0.83%)
After-hours: Nov 20, 2024, 7:04 PM EST
Atossa Therapeutics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Selling, General & Admin | 13.12 | 14.04 | 12.61 | 11.31 | 8 | 10.62 | |
| Research & Development | 16.37 | 17.33 | 15.08 | 9.21 | 6.61 | 6.65 | |
| Operating Expenses | 29.49 | 31.38 | 27.69 | 20.52 | 14.61 | 17.27 | |
| Operating Income | -29.49 | -31.38 | -27.69 | -20.52 | -14.61 | -17.27 | |
| Interest & Investment Income | 4.45 | 4.34 | 0.88 | 0.01 | - | - | |
| Other Non Operating Income (Expenses) | -0.16 | -0.07 | -0.15 | -0.09 | -3.22 | 0.03 | |
| EBT Excluding Unusual Items | -25.2 | -27.1 | -26.96 | -20.61 | -17.83 | -17.24 | |
| Gain (Loss) on Sale of Investments | -1.71 | -2.99 | - | - | - | - | |
| Pretax Income | -26.91 | -30.09 | -26.96 | -20.61 | -17.83 | -17.24 | |
| Earnings From Continuing Operations | -26.91 | -30.09 | -26.96 | -20.61 | -17.83 | -17.24 | |
| Net Income | -26.91 | -30.09 | -26.96 | -20.61 | -17.83 | -17.24 | |
| Preferred Dividends & Other Adjustments | - | - | - | - | 4.5 | - | |
| Net Income to Common | -26.91 | -30.09 | -26.96 | -20.61 | -22.33 | -17.24 | |
| Shares Outstanding (Basic) | 126 | 126 | 127 | 117 | 11 | 8 | |
| Shares Outstanding (Diluted) | 126 | 126 | 127 | 117 | 11 | 8 | |
| Shares Change (YoY) | -0.70% | -0.43% | 8.27% | 934.13% | 33.09% | 104.36% | |
| EPS (Basic) | -0.21 | -0.24 | -0.21 | -0.18 | -1.97 | -2.03 | |
| EPS (Diluted) | -0.21 | -0.24 | -0.21 | -0.18 | -1.97 | -2.03 | |
| Free Cash Flow | -19.57 | -20.96 | -20.79 | -16.48 | -11.58 | -9.14 | |
| Free Cash Flow Per Share | -0.16 | -0.17 | -0.16 | -0.14 | -1.02 | -1.08 | |
| EBITDA | -29.46 | -31.35 | -27.68 | -20.5 | -14.56 | -17.21 | |
| D&A For EBITDA | 0.03 | 0.02 | 0.01 | 0.02 | 0.05 | 0.05 | |
| EBIT | -29.49 | -31.38 | -27.69 | -20.52 | -14.61 | -17.27 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.